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Hemophagocytic​ ​lymphohistiocytosis​ ​(HLH)​ ​is​ ​a​ ​hyperinflammatory​ ​syndrome 
characterized​ ​by​ ​unregulated​ ​macrophage​ ​and​ ​T-lymphocyte​ ​activation​ ​resulting​ ​in 
cytokine​ ​overproduction​ ​and​ ​subsequent​ ​histiocytic​ ​phagocytosis.​ ​Variant​ ​infections, 
particularly​ ​viruses​ ​have​ ​been​ ​postulated​ ​as​ ​the​ ​inciting​ ​factor​ ​for​ ​this​ ​potentially​ ​fatal 




Human​ ​granulocytic​ ​anaplasmosis​ ​(HGA)​ ​is​ ​a​ ​tick-borne​ ​disease​ ​caused​ ​by​ ​Anaplasma 
phagocytophilum​ ​infection​ ​that​ ​is​ ​transmitted​ ​through​ ​Ixodes​ ​tick.[sup][1],[2],[3]​ ​Initial 
symptoms​ ​typically​ ​present​ ​1–2​ ​weeks​ ​after​ ​being​ ​bitten​ ​by​ ​an​ ​infected​ ​tick.​ ​The​ ​clinical 
presentation​ ​is​ ​broad​ ​ranging​ ​from​ ​a​ ​mild​ ​flu-like​ ​illness​ ​characterized​ ​by​ ​fever/chills, 
headaches,​ ​myalgias,​ ​and​ ​malaise​ ​to​ ​serious​ ​and​ ​potentially​ ​fatal​ ​disease​ ​including 
disseminated​ ​intravascular​ ​coagulopathy​ ​if​ ​not​ ​detected​ ​and​ ​treated 
appropriately.[sup][1],[2],[3]​ ​We​ ​propose​ ​that​ ​one​ ​of​ ​the​ ​more​ ​severe​ ​complications​ ​may 
be​ ​hemophagocytic​ ​lymphohistiocytosis​ ​(HLH).​ ​HLH​ ​is​ ​a​ ​hyperinflammatory​ ​syndrome 
characterized​ ​by​ ​unregulated​ ​macrophage​ ​and​ ​T-lymphocyte​ ​activation​ ​resulting​ ​in 
cytokine​ ​overproduction,​ ​hemophagocytosis,​ ​and​ ​tissue​ ​destruction.[sup][4]​ ​HLH​ ​is 
associated​ ​with​ ​various​ ​malignancies,​ ​autoimmune​ ​diseases,​ ​and​ ​infections.[sup][5],[6] 
An​ ​association​ ​between​ ​macrophage​ ​activation​ ​and​ ​anaplasmosis​ ​has​ ​been​ ​reported​ ​by 





A​ ​case​ ​of​ ​a​ ​63-year-old​ ​male​ ​who​ ​presented​ ​to​ ​an​ ​area​ ​hospital​ ​with​ ​complaints​ ​of​ ​fever 
(104[degrees]F)​ ​and​ ​lethargy​ ​for​ ​1​ ​day.​ ​Three​ ​weeks​ ​before​ ​the​ ​presentation,​ ​he 
underwent​ ​a​ ​root​ ​canal​ ​surgery​ ​for​ ​a​ ​dental​ ​abscess.​ ​At​ ​that​ ​time,​ ​he​ ​received​ ​antibiotic 
prophylaxis.​ ​Patient​ ​also​ ​with​ ​a​ ​history​ ​of​ ​mechanical​ ​aortic​ ​valve​ ​replacement​ ​and 
aortic​ ​root​ ​graft​ ​in​ ​1987​ ​due​ ​to​ ​valvular​ ​insufficiency​ ​and​ ​ascending​ ​aortic​ ​aneurysm, 
respectively.​ ​On​ ​initial​ ​evaluation,​ ​he​ ​was​ ​found​ ​to​ ​have​ ​a​ ​normal​ ​white​ ​blood​ ​cell​ ​count 
with​ ​39%​ ​bandemia​ ​and​ ​thrombocytopenia​ ​at​ ​14​ ​x​ ​109/L.​ ​Blood​ ​and​ ​urine​ ​cultures​ ​were 
drawn​ ​before​ ​starting​ ​empiric​ ​antibiotics​ ​(vancomycin​ ​and​ ​ceftriaxone)​ ​for​ ​presumptive 
endocarditis.​ ​Within​ ​24​ ​h,​ ​the​ ​patient​ ​had​ ​become​ ​leukopenic​ ​(neutrophils​ ​count​ ​2.73​ ​x 
10[sup]9/L)​ ​and​ ​platelets​ ​had​ ​decreased​ ​further​ ​to​ ​11​ ​x​ ​10[sup]9/L.​ ​At​ ​this​ ​time,​ ​he​ ​was 
given​ ​filgrastim​ ​and​ ​platelet​ ​transfusion.​ ​Transthoracic​ ​echocardiogram​ ​was​ ​performed 
and​ ​noted​ ​an​ ​echodensity​ ​on​ ​the​ ​prosthetic​ ​aortic​ ​valve,​ ​and​ ​he​ ​was​ ​transferred​ ​to​ ​our 
institution​ ​for​ ​further​ ​diagnosis​ ​and​ ​treatment. 
 
Upon​ ​arrival​ ​to​ ​our​ ​institution,​ ​the​ ​patient​ ​was​ ​noted​ ​to​ ​have​ ​persistent​ ​fever,​ ​a 
nondiagnostic​ ​physical​ ​examination​ ​with​ ​worsening​ ​oliguric​ ​renal​ ​failure,​ ​and 
thrombocytopenia.​ ​Other​ ​pertinent​ ​laboratory​ ​abnormalities​ ​were​ ​elevated​ ​ferritin 
(65,647​ ​[micro]g/L),​ ​triglycerides​ ​(200​ ​mg/dL),​ ​lactate​ ​dehydrogenase​ ​(2067​ ​unit/L),​ ​and 
soluble​ ​interleukin-2​ ​receptor​ ​(18,834​ ​U/mL)​ ​while​ ​the​ ​fibrinogen​ ​was​ ​decreased​ ​(0.244 
g/L)​ ​[Table​ ​1].​ ​The​ ​hypothesis​ ​of​ ​HLH​ ​was​ ​considered,​ ​and​ ​our​ ​suspicion​ ​was​ ​further 
supported​ ​by​ ​the​ ​development​ ​of​ ​neurologic​ ​symptoms​ ​including​ ​dysarthria​ ​and 
clumsiness​ ​with​ ​fine​ ​motor​ ​skills.​ ​On​ ​further​ ​review,​ ​the​ ​patient​ ​reported​ ​tick​ ​attachment 
in​ ​August​ ​which​ ​was​ ​approximately​ ​1​ ​month​ ​before​ ​presentation.​ ​Doxycycline​ ​was, 
therefore,​ ​initiated​ ​pending​ ​serology​ ​for​ ​tick-borne​ ​illnesses.{Table​ ​1} 
 
Vancomycin​ ​and​ ​ceftriaxone​ ​were​ ​discontinued​ ​after​ ​negative​ ​blood​ ​cultures​ ​and 
transesophageal​ ​echocardiogram,​ ​whereas​ ​doxycycline​ ​was​ ​continued​ ​due​ ​to​ ​high 
suspicion​ ​of​ ​a​ ​tick-borne​ ​illness.​ ​Testing​ ​for​ ​Lyme​ ​disease,​ ​Rickettsiosis,​ ​and 
Babesiosis​ ​returned​ ​negative.​ ​However,​ ​immunoglobulin​ ​G​ ​and​ ​polymerase​ ​chain 
reaction​ ​for​ ​A.​ ​phagocytophilum​ ​were​ ​reactive,​ ​thus​ ​confirming​ ​the​ ​diagnosis​ ​of​ ​HGA. 
With​ ​doxycycline​ ​solely,​ ​the​ ​patient's​ ​symptomatology​ ​and​ ​before-mentioned​ ​laboratory 




HGA​ ​is​ ​a​ ​tick-borne​ ​illness​ ​transmitted​ ​by​ ​Ixodes​ ​species​ ​infected​ ​with​ ​A. 
phagocytophilum,​ ​a​ ​small,​ ​obligate​ ​intracellular​ ​coccobacillus.​ ​Typically​ ​presenting​ ​as​ ​a 
nonspecific​ ​viral​ ​illness,​ ​its​ ​prodrome​ ​is​ ​associated​ ​with​ ​fever,​ ​malaise,​ ​myalgias, 
headache,​ ​and​ ​sometimes​ ​arthralgia.[sup][1]​ ​Laboratory​ ​data​ ​supportive​ ​of 
anaplasmosis​ ​include​ ​thrombocytopenia,​ ​leukopenia,​ ​mild​ ​anemia,​ ​elevated 
transaminases,​ ​especially​ ​aspartate​ ​transaminase,​ ​and​ ​less​ ​commonly​ ​increasing 
serum​ ​creatinine.[sup][1] 
 
High​ ​suspicion​ ​of​ ​HGA​ ​is​ ​probable​ ​upon​ ​visualization​ ​of​ ​morulae​ ​on​ ​peripheral 
smear.[sup][1]​ ​Morulae​ ​are​ ​clusters​ ​of​ ​A.​ ​phagocytophilum​ ​growing​ ​within​ ​cytoplasmic 
vacuoles​ ​of​ ​neutrophils.​ ​However,​ ​this​ ​is​ ​not​ ​the​ ​standard​ ​of​ ​care​ ​for​ ​the​ ​diagnosis,​ ​as 
the​ ​percentage​ ​of​ ​granulocytes​ ​containing​ ​morulae​ ​is​ ​often​ ​low.[sup][2]​ ​Moreover,​ ​to 
make​ ​peripheral​ ​smear​ ​more​ ​sensitive​ ​for​ ​the​ ​diagnosis​ ​most​ ​efficacious,​ ​it​ ​is 
recommended​ ​that​ ​at​ ​least​ ​200​ ​granulocytes​ ​are​ ​examined.[sup][2]​ ​Definitive​ ​diagnosis 
is​ ​based​ ​on​ ​polymerase​ ​chain​ ​reaction​ ​for​ ​A.​ ​phagocytophilum​ ​as​ ​serology​ ​testing​ ​is 
often​ ​negative​ ​during​ ​the​ ​1[sup]st​ ​week​ ​of​ ​illness.[sup][2],[3]​ ​In​ ​our​ ​patient,​ ​no​ ​morulae 
were​ ​identified,​ ​and​ ​this​ ​is​ ​likely​ ​related​ ​to​ ​his​ ​severe​ ​neutropenia.​ ​Diagnosis​ ​was 
confirmed​ ​by​ ​positive​ ​polymerase​ ​chain​ ​reaction​ ​for​ ​A.​ ​phagocytophilum​ ​. 
 
The​ ​associated​ ​clinical​ ​finding​ ​and​ ​laboratory​ ​abnormalities​ ​are​ ​usually​ ​self-limited​ ​and 
resolve​ ​with​ ​7–14​ ​days​ ​of​ ​doxycycline.[sup][3]​ ​However,​ ​our​ ​patient​ ​experienced​ ​a​ ​more 
severe​ ​disease​ ​course​ ​as​ ​exemplified​ ​by​ ​the​ ​development​ ​of​ ​HLH,​ ​a​ ​potentially 
life-threatening​ ​syndrome​ ​triggered​ ​by​ ​increased​ ​cytokine​ ​release​ ​resulting​ ​in​ ​the 
unregulated​ ​activation​ ​of​ ​monocytes​ ​and​ ​macrophages.[sup][4],[5]​ ​This​ ​results​ ​in 
hemophagocytosis​ ​in​ ​the​ ​bone​ ​marrow​ ​and​ ​lymphoid​ ​tissues.​ ​Various​ ​terms​ ​have​ ​been 
used​ ​to​ ​describe​ ​HLH​ ​including​ ​primary​ ​HLH​ ​(also​ ​called​ ​familial​ ​HLH)​ ​which​ ​is​ ​seen​ ​in 
patients​ ​with​ ​gene​ ​mutation;​ ​secondary​ ​(or​ ​sporadic,​ ​acquired)​ ​HLH​ ​seen​ ​in​ ​patients 
without​ ​familial​ ​mutation​ ​and​ ​with​ ​a​ ​known​ ​trigger;​ ​and​ ​macrophage​ ​activation 
syndrome​ ​which​ ​is​ ​seen​ ​in​ ​patients​ ​with​ ​rheumatologic​ ​disorders.​ ​Recognized​ ​triggers 
of​ ​HLH​ ​consist​ ​of​ ​malignancy,​ ​autoimmune​ ​disease,​ ​and​ ​variant​ ​infections.[sup][5],[6] 
Of​ ​the​ ​infectious​ ​triggers,​ ​viruses​ ​in​ ​particular​ ​Epstein–Barr​ ​virus​ ​have​ ​been​ ​most 
commonly​ ​associated​ ​with​ ​HLH.​ ​Other​ ​infectious​ ​causes​ ​include​ ​viruses​ ​(such​ ​as​ ​H1N1 
influenza​ ​virus,​ ​measles​ ​virus,​ ​HIV,​ ​human​ ​herpesviruses-8,​ ​herpes,​ ​and​ ​varicella 
zoster​ ​virus),​ ​parasites​ ​(especially​ ​leishmaniasis​ ​and​ ​malaria),​ ​bacteria​ ​(including 
Ehrlichia​ ​,​ ​tuberculosis,​ ​and​ ​brucella),​ ​and​ ​fungi.[sup][6] 
 
HLH​ ​is​ ​diagnosed​ ​based​ ​on​ ​fulfillment​ ​of​ ​five​ ​of​ ​the​ ​eight​ ​criteria.[sup][4],[5]​ ​These 
criteria​ ​include​ ​fever;​ ​splenomegaly;​ ​cytopenias​ ​affecting​ ​at​ ​least​ ​2​ ​lineages;​ ​elevated 
triglycerides​ ​and/or​ ​low​ ​fibrinogen;​ ​hemophagocytosis​ ​evident​ ​on​ ​examination​ ​of​ ​bone 
marrow,​ ​spleen,​ ​or​ ​lymph​ ​nodes;​ ​reduced​ ​to​ ​absent​ ​natural​ ​killer​ ​cell​ ​activity;​ ​elevated 
ferritin​ ​>500​ ​[micro]g/L;​ ​and​ ​a​ ​high​ ​soluble​ ​CD25​ ​(interleukin-2​ ​receptor).[sup][4],[5]​ ​The 
criterion​ ​fulfilled​ ​in​ ​our​ ​patient​ ​included​ ​fever,​ ​bicytopenia​ ​with​ ​leukopenia​ ​and 
thrombocytopenia,​ ​hypertriglyceridemia,​ ​elevated​ ​ferritin,​ ​and​ ​high​ ​soluble​ ​interleukin-2 
receptor. 
 
A.​ ​phagocytophilum​ ​as​ ​a​ ​cause​ ​of​ ​HLH​ ​was​ ​first​ ​reported​ ​by​ ​Dumier​ ​et​ ​al​ ​.,​ ​who 
reported​ ​on​ ​29​ ​patients​ ​with​ ​corroborated​ ​HGA​ ​ranging​ ​mild​ ​to​ ​fatal​ ​disease.[sup][7] 
Severely​ ​affected​ ​patients​ ​had​ ​fever,​ ​cytopenia,​ ​elevated​ ​Interferon​ ​gamma​ ​levels, 
hepatic​ ​injury,​ ​elevated​ ​ferritin​ ​level,​ ​and​ ​elevated​ ​triglycerides.​ ​Patients​ ​with​ ​fatal 
disease​ ​were​ ​found​ ​on​ ​autopsy​ ​to​ ​hemophagocytic​ ​macrophages​ ​in​ ​their​ ​spleen​ ​and 
other​ ​organs,​ ​consistent​ ​with​ ​current​ ​diagnostic​ ​criteria​ ​for​ ​macrophage​ ​activation​ ​and 
hemophagocytic​ ​syndromes.[sup][7]​ ​The​ ​data​ ​presented​ ​by​ ​Dumier​ ​et​ ​al​ ​.​ ​provide 
evidence​ ​that​ ​infection​ ​with​ ​A.​ ​phagocytophilum​ ​may​ ​represent​ ​manifestations​ ​of 
macrophage​ ​activation​ ​and​ ​that​ ​the​ ​clinical​ ​severity​ ​could​ ​be​ ​dependent​ ​on​ ​the​ ​degree 
of​ ​macrophage​ ​activation.[sup][7]​ ​Macrophage​ ​activation​ ​syndrome​ ​and​ ​HLH​ ​should​ ​be 
considered​ ​as​ ​an​ ​advanced​ ​complication​ ​of​ ​anaplasmosis,​ ​especially​ ​when​ ​diagnosis 
and​ ​treatment​ ​are​ ​delayed.​ ​Although​ ​treatment​ ​for​ ​HLH​ ​typically​ ​entails​ ​chemotherapy 
and​ ​immunosuppressive​ ​agents,​ ​our​ ​patient's​ ​symptomatology​ ​reverted​ ​with 
doxycycline​ ​only,​ ​thus​ ​additionally​ ​supporting​ ​our​ ​belief​ ​that​ ​HLH​ ​was​ ​incited​ ​by 
anaplasmosis. 
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